Skip to main content
SpringerLink
Log in

The neuroimaging of Leigh syndrome: case series and review of the literature

  • Review
  • Published:
Pediatric Radiology Aims and scope Submit manuscript

Abstract

Leigh syndrome by definition is (1) a neurodegenerative disease with variable symptoms, (2) caused by mitochondrial dysfunction from a hereditary genetic defect and (3) accompanied by bilateral central nervous system lesions. A genetic etiology is confirmed in approximately 50% of patients, with more than 60 identified mutations in the nuclear and mitochondrial genomes. Here we review the clinical features and imaging studies of Leigh syndrome and describe the neuroimaging findings in a cohort of 17 children with genetically confirmed Leigh syndrome. MR findings include lesions in the brainstem in 9 children (53%), basal ganglia in 13 (76%), thalami in 4 (24%) and dentate nuclei in 2 (12%), and global atrophy in 2 (12%). The brainstem lesions were most frequent in the midbrain and medulla oblongata. With follow-up an increased number of lesions from baseline was observed in 7 of 13 children, evolution of the initial lesion was seen in 6, and complete regression of the lesions was seen in 3. No cerebral white matter lesions were found in any of the 17 children. In concordance with the literature, we found that Leigh syndrome follows a similar pattern of bilateral, symmetrical basal ganglia or brainstem changes. Lesions in Leigh syndrome evolve over time and a lack of visible lesions does not exclude the diagnosis. Reversibility of lesions is seen in some patients, making the continued search for treatment and prevention a priority for clinicians and researchers.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Fabian B, Rodenburg RJ, Schaper J et al (2014) A guide to diagnosis and treatment of Leigh syndrome. J Neurol Neurosurg Psychiatry 85:257–265

    Article  Google Scholar 

  2. Finsterer J (2008) Leigh and Leigh-like syndrome in children and adults. Pediatr Neurol 39:223–235

    Article  PubMed  Google Scholar 

  3. Koenig MK (2008) Presentation and diagnosis of mitochondrial disorders in children. Pediatr Neurol 38:305–313

    Article  PubMed  PubMed Central  Google Scholar 

  4. Finsterer J (2009) Central nervous system imaging in mitochondrial disorders. Can J Neurol Sci 36:143–153

    Article  PubMed  Google Scholar 

  5. Finsterer J (2006) Central nervous system manifestations of mitochondrial disorders. Acta Neurol Scand 114:217–238

    Article  CAS  PubMed  Google Scholar 

  6. Sofou K, Steneryd K, Wiklund LM et al (2013) MRI of the brain in childhood-onset mitochondrial disorders with central nervous system involvement. Mitochondrion 13:364–371

    Article  CAS  PubMed  Google Scholar 

  7. Leigh D (1951) Subacute necrotizing encephalomyelopathy in an infant. J Neurol Neurosurg Psychiatry 14:216–221

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Yashon D, Jane JA (1967) Subacute necrotizing encephalomyelopathy of infancy and childhood. J Clin Pathol 20:28–37

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Lakke JP, Ebels EJ, Thye OJT (1967) Infantile necrotizing encephalomyelopathy (Leigh). Arch Neurol 16:227–231

    Article  CAS  PubMed  Google Scholar 

  10. Dayan AD, Ockenden BG, Crome L (1970) Necrotizing encephalomyelopathy of Leigh. Neuropathological findings in 8 cases. Arch Dis Child 45:39–48

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. (1971) Encephalomyelopathy of Leigh. Br Med J 2:238

  12. Willems JL, Monnens LA, Trijbels JM et al (1977) Leigh’s encephalomyelopathy in a patient with cytochrome C oxidase deficiency in muscle tissue. Pediatrics 60:850–857

    CAS  PubMed  Google Scholar 

  13. Wick R, Scott G, Byard RW (2007) Mechanisms of unexpected death and autopsy findings in Leigh syndrome (subacute necrotising encephalomyelopathy). J Forensic Leg Med 14:42–45

    Article  PubMed  Google Scholar 

  14. McKelvie P, Infeld B, Marotta R et al (2012) Late-adult onset Leigh syndrome. J Clin Neurosci 19:195–202

    Article  PubMed  Google Scholar 

  15. Fassone E, Wedatilake Y, DeVile CJ et al (2013) Treatable Leigh-like encephalopathy presenting in adolescence. BMJ Case Rep 2013:200838

    PubMed  Google Scholar 

  16. Levy RJ, Rios PG, Akman HO et al (2014) Long survival in patients with Leigh syndrome and the m.10191T>C mutation in MT-ND3: a case report and review of the literature. J Child Neurol 29:NP105–NP110

    Article  PubMed  PubMed Central  Google Scholar 

  17. De Vivo DC, Haymond MW, Obert KA et al (1979) Defective activation of the pyruvate dehydrogenase complex in subacute necrotizing encephalomyelopathy (Leigh disease). Ann Neurol 6:483–494

    Article  Google Scholar 

  18. Sakushima K, Tsuji-Akimoto S, Niino M et al (2011) Adult Leigh disease without failure to thrive. Neurologist 17:222–227

    Article  PubMed  Google Scholar 

  19. Procaccio V, Wallace DC (2004) Late-onset Leigh syndrome in a patient with mitochondrial complex I NDUFS8 mutations. Neurology 62:1899–1901

    Article  PubMed  PubMed Central  Google Scholar 

  20. Takahashi S, Oki J, Miyamoto A et al (1999) Proton magnetic resonance spectroscopy to study the metabolic changes in the brain of a patient with Leigh syndrome. Brain Dev 21:200–204

    Article  CAS  PubMed  Google Scholar 

  21. Arii J, Tanabe Y (2000) Leigh syndrome: serial MR imaging and clinical follow-up. AJNR Am J Neuroradiol 21:1502–1509

    CAS  PubMed  Google Scholar 

  22. Van Erven PM, Ruitenbeek W, Gabreels FJ et al (1986) Disturbed oxidative metabolism in subacute necrotizing encephalomyelopathy (Leigh syndrome). Neuropediatrics 17:28–32

    Article  PubMed  Google Scholar 

  23. Miranda AF, Ishii S, DiMauro S et al (1989) Cytochrome C oxidase deficiency in Leigh’s syndrome: genetic evidence for a nuclear DNA-encoded mutation. Neurology 39:697–702

    Article  CAS  PubMed  Google Scholar 

  24. Nagai T, Goto Y, Matsuoka T et al (1992) Leigh encephalopathy: histologic and biochemical analyses of muscle biopsies. Pediatr Neurol 8:328–332

    Article  CAS  PubMed  Google Scholar 

  25. Bourgeron T, Rustin P, Chretien D et al (1995) Mutation of a nuclear succinate dehydrogenase gene results in mitochondrial respiratory chain deficiency. Nat Genet 11:144–149

    Article  CAS  PubMed  Google Scholar 

  26. Morris AA, Leonard JV, Brown GK et al (1996) Deficiency of respiratory chain complex I is a common cause of Leigh disease. Ann Neurol 40:25–30

    Article  CAS  PubMed  Google Scholar 

  27. Rahman S, Blok RB, Dahl HH et al (1996) Leigh syndrome: clinical features and biochemical and DNA abnormalities. Ann Neurol 39:343–351

    Article  CAS  PubMed  Google Scholar 

  28. Ogier H, Lombes A, Scholte HR et al (1988) De Toni-Fanconi-Debré syndrome with Leigh syndrome revealing severe muscle cytochrome C oxidase deficiency. J Pediatr 112:734–739

    Article  CAS  PubMed  Google Scholar 

  29. Longo N (2003) Mitochondrial encephalopathy. Neurol Clin 21:817–831

    Article  PubMed  Google Scholar 

  30. Distelmaier F, Koopman WJ, Van Den Heuvel LP et al (2009) Mitochondrial complex I deficiency: from organelle dysfunction to clinical disease. Brain 132:833–842

    Article  PubMed  Google Scholar 

  31. Koopman WJ, Distelmaier F, Smeitink JA et al (2013) OXPHOS mutations and neurodegeneration. EMBO J 32:9–29

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Karkucinska-Wieckowska A, Lebiedzinska M, Jurkiewicz E et al (2011) Increased reactive oxygen species (ROS) production and low catalase level in fibroblasts of a girl with MEGDEL association (Leigh syndrome, deafness, 3-methylglutaconic aciduria). Folia Neuropathol 49:56–63

    CAS  PubMed  Google Scholar 

  33. Martinelli D, Catteruccia M, Piemonte F et al (2012) EPI-743 reverses the progression of the pediatric mitochondrial disease — genetically defined Leigh syndrome. Mol Genet Metab 107:383–388

    Article  CAS  PubMed  Google Scholar 

  34. DiMauro S, De Vivo DC (1996) Genetic heterogeneity in Leigh syndrome. Ann Neurol 40:5–7

    Article  CAS  PubMed  Google Scholar 

  35. Lee H-F, Tsai CR, Chi CS et al (2009) Leigh syndrome: clinical and neuroimaging follow-up. Pediatr Neurol 40:88–93

    Article  PubMed  Google Scholar 

  36. Farina L, Chiapparini L, Uziel G et al (2002) MR findings in Leigh syndrome with COX deficiency and SURF-1 mutations. AJNR Am J Neuroradiol 23:1095–1100

    PubMed  Google Scholar 

  37. Rossi A, Biancheri R, Bruno C et al (2003) Leigh syndrome with COX deficiency and SURF1 gene mutations: MR imaging findings. AJNR Am J Neuroradiol 24:1188–1191

    PubMed  Google Scholar 

  38. Rio M, Lebre AS, De Lonlay P et al (2010) Mitochondrial ND5 mutations mimicking brainstem tectal glioma. Neurology 75:93

    Article  CAS  PubMed  Google Scholar 

  39. Jacobs DA, Markowitz CE, Liebeskind DS et al (2003) The ‘double panda sign’ in Wilson’s disease. Neurology 61:969

    Article  PubMed  Google Scholar 

  40. Thapa R, Ghosh A (2008) Face of the giant panda’ sign in Wilson disease. Pediatr Radiol 38:1355

    Article  PubMed  Google Scholar 

  41. Sonam K, Bindu PS, Gayathri N et al (2013) The ‘double panda’ sign in Leigh disease. J Child Neurol 29:980–982

    Article  PubMed  Google Scholar 

  42. Goyal M, Versnick E, Tuite P et al (2000) Hypertrophic olivary degeneration: metaanalysis of the temporal evolution of MR findings. AJNR Am J Neuroradiol 21:1073–1077

    CAS  PubMed  Google Scholar 

  43. Vattoth S, Ahmed FY, Telford RC et al (2014) Hypertrophic olivary degeneration: review of anatomy, pathology, and imaging. Neurographics 4:114–122

    Article  Google Scholar 

  44. Kinghorn KJ, Kaliakatsos M, Blakely EL et al (2013) Hypertrophic olivary degeneration on magnetic resonance imaging in mitochondrial syndromes associated with POLG and SURF1 mutations. J Neurol 260:3–9

    Article  CAS  PubMed  Google Scholar 

  45. Bindu PS, Taly AB, Sonam K et al (2014) Bilateral hypertrophic olivary nucleus degeneration on magnetic resonance imaging in children with Leigh and Leigh-like syndrome. Br J Radiol 87:20130478

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  46. Lerman-Sagie T, Leshinsky-Silver E, Watemberg N et al (2005) White matter involvement in mitochondrial diseases. Mol Genet Metab 84:127–136

    Article  CAS  PubMed  Google Scholar 

  47. Kartikasalwah A, Lh N (2010) Leigh syndrome: MRI findings in two children. Biomed Imaging Intervention 6:e6

    Google Scholar 

  48. Warmuth-Metz M, Hofmann E, Büsse M et al (1999) Uncommon morphologic characteristics in Leigh’s disease. AJNR Am J Neuroradiol 20:1158–1160

    CAS  PubMed  Google Scholar 

  49. Giribaldi G, Doria-Lamba L, Biancheri R et al (2012) Intermittent-relapsing pyruvate dehydrogenase complex deficiency: a case with clinical, biochemical, and neuroradiological reversibility. Dev Med Child Neurol 54:472–476

    Article  PubMed  Google Scholar 

  50. Cecil KM, Kos RS (2006) Magnetic resonance spectroscopy and metabolic imaging in white matter diseases and pediatric disorders. Top Magn Reson Imaging 17:275–293

    Article  PubMed  Google Scholar 

  51. José da Rocha A, Túlio Braga F, Carlos Martins Maia A Jr et al (2008) Lactate detection by MRS in mitochondrial encephalopathy: optimization of technical parameters. J Neuroimaging 18:1–8

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Diagnostic and Interventional Imaging, The University of Texas Medical School at Houston, 6431 Fannin St., MSB 2130b, Houston, TX, 77030, USA

    Eliana Bonfante

  2. Department of Pediatrics, Division of Child and Adolescent Neurology, Mitochondrial Center of Excellence Leigh Clinic, The University of Texas Medical School at Houston, Houston, TX, USA

    Mary Kay Koenig

  3. Department of Pediatrics, Division of Child and Adolescent Neurology, The University of Texas Medical School at Houston, Houston, TX, USA

    Rahmat B. Adejumo & Vinu Perinjelil

  4. Department of Diagnostic and Interventional Imaging, The University of Texas Medical School at Houston, Houston, TX, USA

    Roy F. Riascos

Authors
  1. Eliana Bonfante
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mary Kay Koenig
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Rahmat B. Adejumo
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Vinu Perinjelil
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Roy F. Riascos
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Eliana Bonfante.

Ethics declarations

Conflicts of interest

None

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bonfante, E., Koenig, M.K., Adejumo, R.B. et al. The neuroimaging of Leigh syndrome: case series and review of the literature. Pediatr Radiol 46, 443–451 (2016). https://doi.org/10.1007/s00247-015-3523-5

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00247-015-3523-5

Keywords

Search

Navigation